4.1 Article

Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1

期刊

出版社

WALTER DE GRUYTER GMBH
DOI: 10.1515/JPEM.2011.092

关键词

bone dysplasia; bone health; neurofibromas; neurofibromatosis; vitamin D

资金

  1. Shriners Research Foundation
  2. National Center for Research Resources [M01-RR00064]
  3. National Institute of Neurological Disorders and Stroke [K23 NS052500]
  4. Doris Duke Charitable Foundation
  5. Children's Health Research Center
  6. Center for Pediatric Nutrition Research at the University of Utah
  7. Primary Children's Research Foundation

向作者/读者索取更多资源

Objective: Low 25-hydroxyvitamin D (25OHD) concentrations have been associated with tumors and osteopenia or fractures in adults with neurofibromatosis type 1 (NF1). We report 25OHD concentrations in 109 children with NF1 and 218 controls matched for age, sex, geographic location, and time of year. Methods: Children with NF1 were recruited (n=109; 2-17 years), and clinical data and dual-energy X-ray absorptiometry measurements were obtained. 25OHD concentrations were measured in subjects and controls. Results: More NF1 individuals (50%) were in the 25OHD insufficient or deficient range (<30 ng/mL) (1 ng/mL=2.496 nmol/L) compared to controls (36%) (p=0.0129). 25OHD concentrations were higher in individuals with neurofibromas after controlling for age (p=0.0393), and were negatively associated with whole-body subtotal bone mineral density (BMD) z-scores (p=0.0385). Conclusions: More children with NF1 had 25OHD concentrations <30 ng/mL, potentially because of increased pigmentation and/or decreased sunlight exposure. In contrast to adults, decreased 25OHD concentrations were not associated with neurofibromas, and there was no positive association between 25OHD and BMD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据